Description

FLUSURE™/ER BAC^® PLUS is a freeze-dried preparation containing 2 type A field isolates, subtypes H1N1 and H3N2, of inactivated swine influenza viruses grown on an established cell line, plus a liquid preparation of a serum-free, clarified E. rhusiopathiae culture. The liquid component contains Amphigen^®, a unique oil-in-water adjuvant to enhance the immune response, and is used to rehydrate the freeze-dried vaccine.

Approved Uses

Vaccination of healthy swine 3 weeks of age or older as an aid in preventing respiratory disease caused by swine influenza virus (SIV) subtypes H1N1 and H3N2 and erysipelas caused by Erysipelothrix rhusiopathiae for a period of 20 weeks.

Key Features

• Proven, effective, bivalent swine-flu protection. FluSure aids in the prevention of respiratory disease caused by swine influenza (SIV) subtypes H1N1 and H3N2 – the two subtypes most often diagnosed in U.S. swine herds.
• Safe. In safety studies on hundreds of pigs and pregnant sows, animals vaccinated with FLUSURE showed no systemic reactions. Pigs vaccinated with FLUSURE were 100% injection-site-reaction-free and sows were 99.5% injection-site-reaction-free. Pregnant sows vaccinated with FLUSURE farrowed at similar rates and had pigs born live, born dead and born mummies similar to saline-vaccinated control sows.
• Flexible. The freeze-dried formulation provides for greater flexibility when dosing.
• New Generation. ER BAC PLUS is a new “2nd Generation” vaccine. Older “1st Generation” Erysipelas vaccines only require 2.5 weeks of proven duration of immunity and may leave pigs vulnerable to infection later in the production cycle.
• All the way to market. The duration of immunity of 20 weeks provides for protection all the way to market.

Packaging

50-dose vial, 250-dose vial